Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Operating Leases (2022 - 2025)

Historic Operating Leases for Cellebrite DI (CLBT) over the last 3 years, with Q4 2024 value amounting to $11.0 million.

  • Cellebrite DI's Operating Leases rose 1978.81% to $11.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.0 million, marking a year-over-year increase of 1978.81%. This contributed to the annual value of $11.0 million for FY2024, which is 1978.81% up from last year.
  • As of Q4 2024, Cellebrite DI's Operating Leases stood at $11.0 million, which was up 1978.81% from $9.2 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Operating Leases registered a high of $11.0 million during Q4 2024, and its lowest value of $9.2 million during Q4 2023.
  • Its 3-year average for Operating Leases is $10.2 million, with a median of $10.4 million in 2022.
  • Its Operating Leases has fluctuated over the past 5 years, first crashed by 1155.22% in 2023, then surged by 1978.81% in 2024.
  • Over the past 3 years, Cellebrite DI's Operating Leases (Quarter) stood at $10.4 million in 2022, then decreased by 11.55% to $9.2 million in 2023, then grew by 19.79% to $11.0 million in 2024.
  • Its Operating Leases stands at $11.0 million for Q4 2024, versus $9.2 million for Q4 2023 and $10.4 million for Q4 2022.